Characterizing Exosomes Using Next-Generation Protein Sequencing™

“Next-Generation Protein Sequencing™ has the potential to be even more impactful than DNA sequencing. Proteins are the true effectors in biology because they drive biochemical processes and determine cellular function. When you consider the vast investment in DNA sequencing and compare it to the number of actual cures that have resulted, the impact has been limited. Understanding proteins at a deeper level is what really matters, and this technology has the potential to drive far greater advancements in the future than next-generation DNA sequencing.”  — Fred Kweh, PhD

Dive into this case study to see how KWEHealth is exploring cutting-edge technologies to advance exosome-based therapeutics. They view Next-Generation Protein Sequencing (NGPS™) as a game-changer and are leveraging its capabilities to drive progress in their research. Learn how NGPS is shaping their approach.